Aratana, RaQualia sign agreement to develop two animal health drugs
Under the agreement, Aratana will be granted global rights to develop and commercialise the licensed animal health products. Proof of efficacy in human studies has been achieved with
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.